The 20 Best PIK3CA-Related Overgrowth Spectrum Doctors Near Me in Baltimore, MD

Dr. Antonio Wolff is internationally recognized for his work on breast cancer biomarkers, including HER2. As a practicing oncologist and clinical translational researcher, his research has been pivotal to improve the quality of breast cancer biomarker testing in breast cancer, including HER2 and estrogen receptor testing. Among his leadership accomplishments is ensuring that sophisticated laboratory findings are translated into improved clinical care in breast cancer. He is a Fellow of the American Society of Clinical Oncology (ASCO), a Komen Scholar and a Breast Cancer Research Foundation investigator. He has served as associate editor for Journal of Clinical Oncology, and serves on the National Comprehensive Cancer Network (NCCN) Guideline Steering Committee. He is a leader of the Translational Breast Cancer Research Consortium (TBCRC), and one of the principal investigators of the Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies (EVOLVE) in Metastatic Breast Cancer, which was one of the three disease groups recently awarded by ARPA-H to conduct innovative trials using Advanced Analysis for Precision Cancer Therapy (ADAPT). After many years of service as Breast Committee Chair in the ECOG-ACRIN Clinical Trial Network of the National Cancer Institute (NCI), he was elected in 2024 as Co-Chair of the NCI Breast Cancer Steering Committee and appointed to the international steering committee of the Oxford Overview Collaborative, which are positions aimed at advancing clinical trials in breast cancer. At Johns Hopkins, he is an elected member of the Miller Coulson Academy of Clinical Excellence and was honored during the 125th Anniversary Living the Hopkins Mission celebrations of the JHU School of Medicine. Dr. Wolff is rated as an Advanced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Triple-Negative Breast Cancer, and Inflammatory Breast Cancer. Dr. Wolff is board certified in American Board Of Internal Medicine.

Julie R. Brahmer, M.D., M.Sc. is the Director of the Thoracic Oncology Program, Professor of Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and the Marilyn Meyerhoff Professor in Thoracic Oncology. She also directs the Kimmel Cancer Center on the Johns Hopkins Bayview campus and is co-principal investigator on Johns Hopkins' National Clinical Trials Network. Dr. Brahmer received her undergraduate degree in Chemistry and Philosophy in 1989 from the Creighton University in Omaha, Nebraska and went on to receive her medical degree from the University of Nebraska Medical Center College of Medicine in 1993. Completing her internship and residency in Internal Medicine at the University of Utah, Dr. Brahmer later became the Chief Medical Resident until moving to Baltimore to complete her fellowship in Medical Oncology at the Kimmel Cancer Center at Johns Hopkins. Dr. Brahmer is an active clinical leader in the treatment of lung cancer and mesothelioma. She leads the organization of the multidisciplinary thoracic malignancy conference whose members meet weekly to discuss thoracic malignancy cases that need a multidisciplinary review/approach. Dr. Brahmer's research and clinical practice focuses on the development of new therapies for the treatment and prevention of lung cancer and mesothelioma. Dr. Brahmer's research interests include leading early phase immunotherapy trials of anti-PD-1 antibodies, international phase III studies of immunotherapies in lung cancer and investigator-initiated trials evaluating epigenetic therapies in combination with immunotherapies. She is a member of the American Society of Clinical Oncology and the Eastern Cooperative Oncology Group (ECOG) Thoracic Committee and Cancer Prevention Steering Committee. She is one of the founding Board members for the National Lung Cancer Partnership (formerly Women Against Lung Cancer). Within the National Lung Cancer Partnership, she currently serves as a member and the Chairman of the Scientific Executive Committee. She is also on the medical advisory board of the Lung Cancer Research Fund and the Mesothelioma Applied Research Foundation. Dr. Brahmer is rated as an Experienced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC). Dr. Brahmer is board certified in American Board Of Internal Medicine.

Dr. Nilofer S. Azad is Professor of Oncology at Johns Hopkins University School of Medicine and serves as the Associate Cancer Center Director for Clinical Research for the Johns Hopkins Sidney Kimmel Cancer Center. Dr. Azad earned her medical degree and completed a residency in internal medicine at Baylor College of Medicine in Houston, Texas. She then completed a fellowship in oncology and hematology at the National Institute of Health's National Cancer Institute in Bethesda, Maryland where she served as chief fellow. Dr. Azad’s research focused on early phase drug development and the intersection of moving exciting laboratory findings into patients for new treatment options Dr. Azad joined the faculty at the Kimmel Cancer Center in 2008. Dr. Azad’s clinical expertise is in cancers of the gastrointestinal tract, with a concentration in colorectal cancer, cholangiocarcinoma and pancreaticobiliary tract cancer. Her research efforts are dedicated to developing new drug combinations for patients with advanced cancer. In particular, Dr. Azad’s laboratory and clinical trials explore epigenetic therapy in combination with chemotherapy and immunotherapy to improve survival for patients, as well as molecularly targeted drugs. She is an active clinical trialist, leading multiple clinical trials of molecularly targeted agents for advanced cancer patients. Dr. Azad has received numerous grants for her work from entities such as the NCI (National Cancer Center), American Cancer Society, American Society of Clinical Research, Breakthrough Cancer Foundation, the Lustgarten Foundation, The Gateway Foundation, and the National Comprehensive Cancer Network, among others. She served as Principal for Johns Hopkins on the AACR Stand Up 2 Cancer Colorectal Cancer Dream Team and is a member of the Stand Up 2 Cancer Epigenetics Dream Team, leading the GI cancer initiatives for the group. Dr. Azad is a national leader in GI cancer, including serving as a member of the national NCI Colon Cancer Task Force and as Co-Chair of the Scientific and Medical Advisory Board for the Cholangiocarcinoma Foundation. She has a presidential appointment to the National Cancer Advisory Board. Dr. Azad is rated as an Experienced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Colorectal Cancer, Pancreatic Cancer, Hepato-Pancreato-Biliary Surgery, and Colonoscopy. Dr. Azad is board certified in American Board Of Internal Medicine.

Dr. Lam treats patients with lung cancer, esophageal cancer, mesothelioma, and other thoracic cancers. He directs the Thoracic Oncology Clinical Research Program and the Esophageal Cancer Research Program at Johns Hopkins. Dr. Lam is a clinical and translational researcher with a focus on cancer genomics, liquid biopsies, and novel immunotherapies such as vaccines and cell therapies. He has been recognized with a Conquer Cancer Foundation/ASCO Career Development Award, an LCFA/IASLC/BMS Young Investigator Award, and as a Gilead Research Scholar. Dr. Lam is rated as an Experienced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Hepatectomy, and Hepato-Pancreato-Biliary Surgery.

Dr. Santa-Maria completed his oncology training at Johns Hopkins, and has been focused on caring for patients with breast cancer since then. He works as both a primary oncologist and consultant for patients with all types and stages of breast cancer. His research interest is in developing new types of treatment for patients with breast cancer using immunotherapy. Dr. Santa is rated as an Experienced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, and Paget Disease of the Breast. Dr. Santa is board certified in American Board Of Internal Medicine.

Dr. Comi graduated from SUNY Buffalo School of Medicine and received her training in pediatrics at the Children's Hospital of Buffalo and her child neurology training at Johns Hopkins Medicine. Her clinical specialization is in the treatment of the neurological aspects of Sturge-Weber syndrome and other disorders related to capillary malformation. Dr. Comi's clinical research interests focus on improving the early diagnosis and treatment of brain involvement in Sturge-Weber syndrome in order to prevent ischemic brain injury in affected infants and young children, and on studies to understand what causes Sturge-Weber syndrome. Her laboratory research work deals with the pathogenesis of Sturge-Weber syndrome, recently shown to be caused by a somatic mutation, and on developing new drug targets, screening assays, models and therapeutic strategies for Sturge-Weber syndrome. Her lab group also works on developing better neuroprotective and neuroregenerative responses to brain injury resulting from impaired blood flow to the brain. Dr. Comi is rated as an Experienced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. She is also highly rated in 22 other conditions, according to our data. Her clinical expertise encompasses Sturge-Weber Syndrome, Parkes Weber Syndrome, Stork Bite, Epilepsy in Children, and Endovascular Embolization. Dr. Comi is board certified in American Board Of Psychiatry And Neurology.

Dr. Elham Afghani is an assistant professor of Medicine at the Johns Hopkins University School of Medicine. She joins us from Cedars Sinai Medical Center in Los Angeles. She received her medical degree from University of California, Irvine. She completed her internal medicine residency as well as an extra year as chief resident at the University of California, Irvine, Medical Center. She then completed her gastroenterology and hepatology fellowship with additional training in pancreatic diseases at the Johns Hopkins University School of Medicine. With a unique specialization in pancreatic disease, she has participated in numerous research projects at the Cedars Sinai division of pancreatico-biliary diseases and was involved in a U01 Consortium for the study of chronic pancreatitis, diabetes and pancreatic cancer. Dr. Afghani’s areas of expertise include acute and chronic pancreatitis, pancreatic cysts and pancreatic exocrine insufficiency. She is an accomplished researcher with multiple publications in prestigious peer-reviewed journals as well as presentations at national meetings. Dr. Afghani is rated as an Experienced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Hereditary Pancreatitis, Acute Pancreatitis, Chronic Pancreatitis, Endoscopy, and Lithotripsy. Dr. Afghani is board certified in American Board Of Internal Medicine.

Eric Christenson is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Christenson is rated as an Experienced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Pancreatic Ductal Adenocarcinoma. Dr. Christenson is board certified in American Board Of Internal Medicine.

Dr. Matthias Holdhoff is a medical oncologist and co-director of the Brain Cancer Disease Group at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. He is a professor of oncology, neurology and neurological surgery at Johns Hopkins University School of Medicine. Dr. Holdhoff’s expertise is in primary brain cancers and central nervous system lymphomas. He earned his medical degree from Freie Universität Berlin, received his doctorate degree at Charité University Medicine Berlin. Dr. Holdhoff completed residency training in internal medicine at Johns Hopkins Bayview Medical Center, followed by a fellowship in medical oncology at Johns Hopkins Hospital with research training at the Ludwig Center for Cancer Genetics and Therapeutics (Kinzler-Vogelstein lab). As a clinical investigator in neuro-oncology, his research is focused on novel trials and translational biomarker studies in malignant gliomas and primary central nervous system lymphomas. He has led and contributed to numerous clinical trials, publications and presentations. Dr. Holdhoff serves as the director of the solid tumor inpatient service at the Sidney Kimmel Comprehensive Cancer Center. He is passionately involved in mentoring and teaching of fellows, residents and students. He is the director of the UCNS-certified neuro-oncology fellowship program at Johns Hopkins, and he is a teaching attending physician for the Osler internal medicine residency program. Dr. Holdhoff is rated as an Experienced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Glioma, Glioblastoma, Astrocytoma, and Brain Tumor. Dr. Holdhoff is board certified in American Board Of Internal Medicine.

James Stuart Ferriss is an associate professor in the Johns Hopkins Department of Gynecology and Obstetrics and director of the F.J. Montz Gynecologic Oncology Fellowship Program. He is an expert in the care of women with cancers of the uterus, cervix, vulva, vagina, fallopian tubes and ovaries. Dr. Ferriss is passionate about minimally invasive approaches to surgery and has extensive experience with robotic surgery. Dr. Ferriss received his undergraduate and medical degrees from Louisiana State University. He then completed his residency in obstetrics and gynecology at the University of Texas Southwestern Medical Center and his fellowship in gynecologic oncology at the University of Virginia. Prior to joining Johns Hopkins, Dr. Ferriss was associate professor in the departments of women’s health and oncology at the University of Texas at Austin Dell Medical School. Before that, he was assistant professor in the department of obstetrics, gynecology and reproductive sciences at Temple University in Philadelphia. Dr. Ferriss’ research is focused on innovations in surgical and clinical education. Dr. Ferriss serves on a variety of boards and is a member of the Society of Gyneocologic Oncology, Mid-Atlantic Gynecologic Oncology Society, American Society of Clinical Oncology, the American College of Surgeons and the American Congress of Obstetricians and Gynecologists. He has been recognized with several awards and honors, including being named a top doctor for outstanding patient care. Dr. Ferriss’ passion for getting to know each of his patients’ values and personal treatment goals and empowering them to be active participants in their treatment defines his approach to patient care. Dr. Ferriss has special interest in supporting his patients through the entire arc of their cancer care from diagnosis to surgery, chemotherapy, and survivorship and palliative care. Videos Dr. Stuart FerrissGynecologic Oncologist Contact for Research Inquiries 600 N. Wolfe St Phipps 281 Baltimore, MD 21287 Research Summary Dr. Ferriss’ research currently focuses on increasing the diversity of patients recruited to clinical trials by understanding the factors and circumstances that prevent some patients from participating. He is also focused on innovations in surgical and clinical education. Dr. Ferriss is rated as an Experienced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Carcinoma of the Cervix, Cervical Cancer, Ovarian Cancer, Oophorectomy, and Lymphadenectomy. Dr. Ferriss is board certified in American Board Of Obstetrics And Gynecology.

Dr. Dalton is an Assistant Professor of Oncology at The Johns Hopkins University School of Medicine. He is active in the Division of Hematology Malignancies, Leukemia Program at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Dr. Dalton has expertise in myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), myeloproliferative neoplasms (MPN), and acute lymphoblastic leukemia (ALL). Dr. Dalton received a combined M.D./Ph.D. degree through the Medical Scientist Training Program at Emory University School of Medicine. He completed a residency in internal medicine and a fellowship in medical oncology at Johns Hopkins. He joined the Johns Hopkins faculty in 2017. Dr. Dalton is a member of the American Society of Hematology and the American Society of Clinical Oncology. Dr. Dalton's primary research is to better understand the genetic events that drive MDS and AML and to develop new therapeutic approaches against these diseases. Dr. Dalton is rated as an Experienced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Aspiration, and Pancreaticoduodenectomy. Dr. Dalton is board certified in American Board Of Internal Medicine.

Dr. Gary Gallia's specialty is endoscopic endonasal surgical approaches to skull base pathologies with a focus on neurosurgical oncology. He utilizes the latest techniques in preoperative imaging, computer-guided surgical navigation, intraoperative monitoring, and minimally invasive and Neuroendoscopy approaches in the management of patients with benign and malignant brain tumors, metastatic tumors to the brain, skull base neoplasms, and pituitary tumors. He is the director of the Neurosurgery Skull Base Center and surgical director of the Johns Hopkins Pituitary Center. Dr. Gary Gallia graduated summa cum laude from the Gibbons Scholar MD/PhD program at Jefferson Medical College and Thomas Jefferson University. He completed his general surgery internship at The Johns Hopkins Hospital where he was awarded surgical intern of the year. He then completed his neurological surgery residency and a postdoctoral fellowship in neuro-oncology at The Johns Hopkins Hospital. Following residency, he completed a minimally invasive and endoscopic neurosurgery fellowship with Dr. Charles Teo at the Prince of Wales Private Hospital and Sydney Children's Hospital in Sydney, Australia. Dr. Gallia is rated as an Experienced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Olfactory Neuroblastoma, Chordoma, Pituitary Tumor, Awake Craniotomy, and Craniectomy. Dr. Gallia is board certified in American Board Of Neurological Surgery.

Dr. Paul Ladenson is a professor of medicine at the Johns Hopkins University School of Medicine. He is also a professor of oncology; pathology; and radiology and radiological science. His areas of clinical expertise include Thyroid diseases, Endocrine & Metabolic disorders. Dr. Ladenson is the John Eager Howard Professor of Endocrinology and Metabolism. He earned his M.D. from Harvard Medical School. He completed his residency and performed a fellowship in endocrinology, diabetes and metabolism at Massachusetts General Hospital. Dr. Ladenson's research interests include cardiac actions of thyroid hormone, thyroid cancer and thyroid hormone analogs. He was recognized with the Lewis E. Braverman Lectureship Award at the 82nd Annual Meeting of the American Thyroid Association (ATA) in 2012. Dr. Ladenson is rated as an Experienced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Thyroid Nodule, Adrenal Insufficiency Pediatric, Secondary Adrenal Insufficiency, PIK3CA-Related Overgrowth Spectrum, and Thyroidectomy. Dr. Ladenson is board certified in American Board Of Internal Medicine.

Dr. Michael G. Goggins is a professor of pathology, medicine and oncology at the Johns Hopkins University School of Medicine. He serves as director of the Pancreatic Cancer Early Detection Laboratory and is an attending physician in medicine in the Division of Gastroenterology and Hepatology at The Johns Hopkins Hospital. He is the Sol Goldman Professor of Pancreatic Cancer Research. Dr. Goggins’ research interests include developing tests to improve the early detection in pancreas cancer, evaluating outcomes of pancreatic surveillance and identifying gene variants responsible for inherited susceptibility to pancreatic cancer. He obtained his medical degree in 1988 from Trinity College of the University of Dublin, Ireland. He completed a residency in internal medicine and a fellowship in Gastroenterology at St. James' Hospital in Dublin. He obtained his Membership of the Royal College of Physicians of Ireland in 1991 and his European Diploma in Gastroenterology in 1995. He joined the Johns Hopkins faculty in 1999. Dr. Goggins is a member of the Royal College of Physicians of Ireland. He sits on the editorial boards of Gut. Dr. Goggins is rated as an Experienced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Familial Pancreatic Cancer, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatectomy, and Pancreaticoduodenectomy.

Jie Chen is a Holistic Medicine provider practicing medicine in Silver Spring, Maryland. Ms. Chen is rated as an Experienced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. She is also highly rated in 22 other conditions, according to our data. Her clinical expertise encompasses Microsporidiosis, Pancreatic Ductal Adenocarcinoma, Gallbladder Disease, Endoscopy, and Osteotomy. Ms. Chen is currently accepting new patients.

Charles Balch is a General Surgeon practicing medicine in Baltimore, Maryland. Dr. Balch is rated as an Advanced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Melanoma, PIK3CA-Related Overgrowth Spectrum, Breast Cancer, and Mastectomy.

Stephen Chanock is a Pediatrics provider practicing medicine in Potomac, Maryland. Dr. Chanock is rated as an Advanced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Mosaicism, Menopause, Gliomatosis Cerebri, Esophageal Cancer, and Hormone Replacement Therapy (HRT).

Jonathan Zember is a Pediatric Radiologist practicing medicine in Silver Spring, Maryland. Dr. Zember is rated as an Experienced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. His clinical expertise encompasses Cantu Syndrome, Simpson-Golabi-Behmel Syndrome, Megalencephaly-Capillary Malformation Syndrome, and Hemi 3 Syndrome.

Ramon Sanchez is a Pediatric Radiologist practicing medicine in Silver Spring, Maryland. Dr. Sanchez is rated as an Experienced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Hirschsprung Disease, Scoliosis, Spondylocarpotarsal Synostosis Syndrome, and Caudal Regression Syndrome.

Takeo Fujii is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Fujii is rated as an Experienced provider by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Triple-Negative Breast Cancer, and PIK3CA-Related Overgrowth Spectrum. Dr. Fujii is board certified in American Board Of Internal Medicine.